Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
Blueprint for EECA countries, first edition
Up-to-date Literature review current through: Jan 2015. | This topic last updated: Jan 29, 2015.
MMWR Morbidity and Mortality Weekly Report December 19, 2014 / 63(50);1205-1206
DHS Working Papers No. 106
Training Programme for Health Professionals
PLOS Medicine | www.plosmedicine.org
January 2013 | Volume 10 | Issue 1 | e1001371
DHS Working Papers No. 89
Cовершенствование теоретических знаний и практических навыков по вопросам диагностики и лечения туберкулеза с множественной лекарственной устойчивостью (МЛУ) ми...кобактерий.
more
Strengthening Parmaceutical Systems. 2nd edition
PLoS Medicine Vol. 6 no. 10 (2009) e1000165